W
Wenpeng Liu
Researcher at Hebei Medical University
Publications - 11
Citations - 285
Wenpeng Liu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 6 publications receiving 180 citations.
Papers
More filters
Journal ArticleDOI
miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Ling Li,Lei Kang,Wei Zhao,Yingying Feng,Wenpeng Liu,Tao Wang,Haixing Mai,Jun Huang,Siyu Chen,Yingchun Liang,Juqiang Han,Xiaojie Xu,Qinong Ye +12 more
TL;DR: Through inhibition of LDHA, miR-30a-5p dampens glycolysis by decreasing glucose uptake, lactate production, ATP generation, and extracellular acidification rate (ECAR), and increasing oxygen consumption rate (OCR) in breast cancer cells.
Journal ArticleDOI
miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
TL;DR: By directly targeting the 3′-UTR (3′-untranslated regions) of IGF-1R, microRNA-342-3p (miR-342 -3p) suppresses IGF- 1R-mediated PI3K/AKT/GLUT1 signaling pathway both in vitro and in vivo.
Journal ArticleDOI
LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC
Luyuan Ma,An Xu,Lei Kang,Rui Cong,Zhongyi Fan,Xiang Zhu,Nan Huo,Wenpeng Liu,Chunyuan Xue,Quanbo Ji,Wen-Chao Li,Zhong Chu,Xiaofeng Kang,Yadong Wang,Zhi-Jia Sun,Yu-Chen Han,Hanxiao Liu,Xiang Gao,Juqiang Han,Hua You,Caiyan Zhao,Xiaojie Xu +21 more
TL;DR: In this paper, the effects of LINC01134/SP1/p62 axis on OXA resistance were evaluated using cell viability, apoptosis, and mitochondrial function and morphology analysis.
Journal ArticleDOI
Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma.
Juqiang Han,Jiarui Li,Yun Qian,Wenpeng Liu,Jiguang Liang,Zhigang Huang,Shuai Wang,Caiyan Zhao +7 more
TL;DR: Plasma miR-148a is a potential non-invasive biomarker for HCC screening, especially for those with negative or low AFP, and might be a complementary approach to AFP for predicting HCC occurrence.
Journal ArticleDOI
ACTR confers to Sorafenib resistance in hepatocellular carcinoma via facilitating the Warburg effect
Luyuan Ma,Wenpeng Liu,An Xu,Quanbo Ji,Yongfu Ma,Yanhong Tai,Yadong Wang,Chuan Shen,Ying Liu,Tao Wang,Juqiang Han,Caiyan Zhao +11 more
TL;DR: This study demonstrated that in sorafenib-resistant HCC xenografts, ACTR was one of the most upregulated genes and provided new clues regarding the role of ACTR as a prospective sensitizing target for sorafinib therapy in HCC.